blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1183031

EP1183031 - QUINOXALINE CONTAINING MEDICAMENTS FOR POST EXPOSURE PROPHYLAXIS OF AN HIV INFECTION [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  28.05.2004
Database last updated on 18.09.2024
Most recent event   Tooltip28.05.2004Withdrawal of applicationpublished on 14.07.2004  [2004/29]
Applicant(s)For all designated states
The Japanese National Institute of Infectious Diseases
1 Hachimandai, Tsukuba
Ibaraki 305-8043 / JP
For all designated states
Mori, Kazuyasu
1-803-603 Takezone
Tsukuba 306-0032 / JP
For all designated states
Yasutomi, Yasuhiro
511-B-42 Kannonji-cho Tsu
Mie 514-0062 / JP
For all designated states
Sugama, Kazushige
2-2-227-14-103 Sakyo
Nara 631-0801 / JP
For all designated states
Sawada, Shuzo
6-19-6 Kanokadai-Kitamachi, Kita-ku
Kobe 651-1513 / JP
For all designated states
Rübsamen-Waigmann, Helga, Prof.Dr.
Königsteiner Strasse 113
65812 Bad Soden / DE
[N/P]
Former [2002/10]For all designated states
The Japanese National Institute of Infectious Diseases
1 Hachimandai, Tsukuba
Ibaraki 305-8043 / JP
For all designated states
Mori, Kazuyasu
1-803-603 Takezone
Tsukuba 306-0032 / JP
For all designated states
Yasutomi, Yasuhiro
511-B-42 Kannonji-cho
Tsu, Mie 514-0062 / JP
For all designated states
Sugama, Kazushige
2-2-227-14-103 Sakyo
Nara 631-0801 / JP
For all designated states
Sawada, Shuzo
6-19-6 Kanokadai-Kitamachi, Kita-ku
Kobe 651-1513 / JP
For all designated states
Rübsamen-Waigman, Helga, Prof.Dr.
Königsteiner Strasse 113
65812 Bad Soden / DE
Inventor(s)01 / Mori, Kazuyasu
1-803-603 Takezone
Tsukuba 306-0032 / JP
02 / Yasutomi, Yasuhiro
511-B-42 Kannonji-cho
Tsu, Mie 514-0062 / JP
03 / Sugama, Kazushige
2-2-227-14-103 Sakyo
Nara 631-0801 / JP
04 / Sawada, Shuzo
6-19-6 Kanokodai-kitamachi, Kita-ku
Kobe 651-1513 / JP
05 / Rübsamen-Waigmann, Helga
Königssteiner Strasse 113
65812 Bad Soden/Taunus / DE
 [2002/10]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastrasse 30
81925 München / DE
[N/P]
Former [2002/10]HOFFMANN - EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Application number, filing date00938669.922.05.2000
[2002/10]
WO2000EP04646
Priority number, dateGB1999001188721.05.1999         Original published format: GB 9911887
[2002/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0071126
Date:30.11.2000
Language:EN
[2000/48]
Type: A1 Application with search report 
No.:EP1183031
Date:06.03.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 30.11.2000 takes the place of the publication of the European patent application.
[2002/10]
Search report(s)International search report - published on:EP30.11.2000
ClassificationIPC:A61K31/495, A61K45/06, A61P31/18
[2002/10]
CPC:
A61K31/00 (EP,US); A61K31/495 (EP,US); A61K31/498 (EP,US);
A61K31/70 (EP,US); A61K31/7068 (EP,US); A61K45/06 (EP,US);
A61P31/18 (EP) (-)
C-Set:
A61K31/495, A61K2300/00 (US,EP);
A61K31/495, A61K31/445 (US,EP);
A61K31/7068, A61K2300/00 (EP,US);
A61K31/7068, A61K31/495 (US,EP);
A61K38/55, A61K31/495 (EP,US)
(-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT [2002/10]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:CHINOXALIN ENTHALTENDE ARZNEIMITTEL ZUR HIV-INFEKTIONSVERHÜTUNG NACH KONTAKT MIT DEM VIRUS[2002/10]
English:QUINOXALINE CONTAINING MEDICAMENTS FOR POST EXPOSURE PROPHYLAXIS OF AN HIV INFECTION[2002/10]
French:MEDICAMENTS CONTENANT DE LA QUINOXALINE DESTINES A LA PROPHYLAXIE D'UNE INFECTION A VIH APRES EXPOSITION[2002/10]
Entry into regional phase21.12.2001National basic fee paid 
21.12.2001Designation fee(s) paid 
21.12.2001Examination fee paid 
Examination procedure11.12.2000Request for preliminary examination filed
International Preliminary Examining Authority: EP
21.12.2001Examination requested  [2002/10]
18.05.2004Application withdrawn by applicant  [2004/29]
Fees paidRenewal fee
27.05.2002Renewal fee patent year 03
13.05.2003Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]DE19703131  (BAYER AG [DE]) [X] 1-15 * claims 1-6 *;
 [X]EP0728481  (BAYER AG [DE]) [X] 1-11 * claims 1-5 *;
 [XD]EP0708093  (HOECHST AG [DE]) [XD] 1-11 * claims 1-4,7-9 * * page 5, line 4 - line 27 *;
 [XD]DE4342024  (HOECHST AG [DE]) [XD] 1-11 * claim 1 * * page 8, line 46 - line 48 * * page 15, line 58 - page 16, line 9 *;
 [A]  - KLEIM J -P ET AL, "ACTIVITY OF A NOVEL QUINOXALINE DERIVATIVE AGAINST HUMAN IMMUNODIFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE AND VIRAL REPLICATION", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,US,AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, (1993), vol. 37, no. 8, ISSN 0066-4804, pages 1659 - 1664, XP000885676 [A] 1-15 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.